Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1978-12-20
1980-03-18
Rose, Shep K.
Drug, bio-affecting and body treating compositions
Lymphokine
435238, A61K 3912
Patent
active
041939913
ABSTRACT:
The present invention relates to the method of protecting dogs against canine parvoviruses. More specifically, the present invention relates to a method of producing an inactivated (killed) canine parvoviral vaccine from a native virulent strain of CPV for use as a vaccine in dogs against disease caused by virulent canine parvoviruses.
REFERENCES:
Binn, L. N. et al., Infection and Immunity 1(5):503-508 (1970), Recovery and Characterization of a Minute Virus of Canines.
Eugster, A. K. et al., Southwestern Vet. 30(1):59-60 (1977), Diarrhea in Puppies:Parvovirus-Like Particles Demonstrated in Their Feces.
Siegl, G., "The Parvoviruses" in Virology Monographs #15, p. 71 (1976), Springer-Verlag, Wien, NY.
Storz, J. et al., Am. J. Vet. Res. (AJVRA)33(1):269-272 (1972), Distribution of Antibodies Against Bovine Parvovirus 1 in Cattle and Other Animal Species.
Appel Max J. G.
Carmichael Leland E.
Cornell Research Foundation Inc.
Rose Shep K.
LandOfFree
Canine parvovirus vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Canine parvovirus vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Canine parvovirus vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1124171